Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / Ordinary Shares, par value US$0.0001 per share
-
Shares outstanding
-
20,679,958
-
Total 13F shares
-
100
-
Share change
-
+100
-
Total reported value
-
$179
-
Price per share
-
$1.79
-
Number of holders
-
1
-
Value change
-
+$179
-
Number of buys
-
1
Institutional Holders of CASI Pharmaceuticals, Inc. - Ordinary Shares, par value US$0.0001 per share (CASI) as of Q4 2022
As of 31 Dec 2022,
CASI Pharmaceuticals, Inc. - Ordinary Shares, par value US$0.0001 per share (CASI) was held by
1 institutional
shareholder
that filed Form 13F with the SEC.
Together, they reported ownership of
100 shares.
The largest 1 holders included
WEST PACES ADVISORS INC..
This page lists
1
institutional shareholders reporting positions in this security
for the Q4 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.